Cowen and Company’s CME Group CME Stock Holding History

Cowen and Company’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-1,650	Closed	-$349K	–	483
2019 Q3	$349K	Buy	+1,650	New	+$345K	0.09%	169

Other funds holding CME

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Cowen and Company's CME Position: Q4 2019 in Review

Cowen and Company sold out of CME Group (CME) in Q4 2019, closing a stake of 1,650 shares — an estimated $349K sold.

Cowen and Company first reported a position in CME in Q3 2019 and held it in 1 quarter. The position peaked at $349K in Q3 2019. 1,061 funds tracked by Wall St. Rank hold CME as of Q4 2019.

Cowen and Company reported no remaining CME Group position as of Q4 2019 after selling out during the quarter.
Cowen and Company sold 1,650 CME Group shares in Q4 2019, an estimated $349K.
Cowen and Company first reported a position in CME Group in Q3 2019 and held it in 1 quarter.
Cowen and Company's CME Group position peaked at $349K in Q3 2019.
1,061 funds tracked by Wall St. Rank held CME Group as of Q4 2019.

Based on Cowen and Company's 13F filing for Q4 2019, filed 11 Feb 2020.